Be careful about MICs to amoxicillin for patients with Streptococci-related infective endocarditis
B. Pilmis(Hôpital Necker-Enfants Malades), Sophie Reissier(Centre Hospitalier Universitaire de Rennes), Vincent Cattoir(Inserm), Marlène Amara(Institut Pasteur), É. Bonnet(Grand Accélérateur National d'Ions Lourds), Audrey Mérens(Hôpital d'Instruction des Armées Bégin), David Boutoille(Inserm), Stéphane Corvec, Olivier Barraud(Inserm), Julie Lourtet-Hascoët(Hôpital Paris Saint-Joseph), Jean‐Ralph Zahar(Inserm), Alban Le Monnier(Université Paris-Saclay), Gauthier Péan de Ponfilly(Hôpital Paris Saint-Joseph), Éva Thomas(Women's Hospital), C. Isnard(Centre Hospitalier Universitaire de Caen Normandie), C. Piau(Hôpital Pontchaillou), Geneviève Héry-Arnaud(Centre Hospitalier Régional Universitaire de Brest), Éric Farfour(European Foundation for Clinical Nanomedicine), Hervé Jacquier(Assistance Publique – Hôpitaux de Paris)
Cited by 22
Related Papers
Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage
|Science|2020|382
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
|The Lancet Infectious Diseases|2021|344
Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature
|Drug Resistance Updates|2018|283
An update on bacterial brain abscess in immunocompetent patients
|Clinical Microbiology and Infection|2017|212
Hospital-acquired pneumonia in ICU
|Anaesthesia Critical Care & Pain Medicine|2017|206